Quotient, Theradiag Announce Dx Partnership
Quotient said that it intends to develop a microarray-based test for connective tissue diseases with Theradiag.
Schott Minifab Acquires Applied Microarrays to Expand US Manufacturing Capabilities
The acquisition will expand Schott's biosensor printing capabilities, helping it further manufacture point-of-care microarray consumables.
PathogenDx Gets CE Mark for Microarray-Based COVID-19 Test
The test has also received Emergency Use Authorization from the US Food and Drug Administration and detects SARS-CoV-2 within three hours of RNA extraction.
The firm said it is also eyeing other testing markets for a platform that does immunohematology, serology, and molecular testing.
PathoNext to Offer Agendia's Breast Cancer Recurrence Assays in Germany
PathoNext will run Agendia's assays in its labs using next-generation sequencing and work with HiSS, Agendia's German distributor, to offer the tests to German patients.